SCHEMBL3451350

SCHEMBL3451350

COC(=O)c1ccc(COc2c(C)cc(C(C)(C)c3ccc(C(C)(c4cc(C)c(OCc5ccc(C(=O)OC)cc5)c(C=O)c4)c4cc(C)c(OCc5ccc(C(=O)OC)cc5)c(C=O)c4)cc3)cc2C=O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.42
LMNA P02545 5/20 0.42
MAPT P10636 5/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.40
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 4/20 0.39
NPC1 O15118 3/20 0.39
MEN1 O00255 3/20 0.39
HTT P42858 2/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
ERN1 O75460 1/20 0.37
KCNH2 Q12809 1/20 0.37
CCR5 P51681 1/20 0.37
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3451283 0.88 SMN1; SMN2 (0.38) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL3453335 0.84 ALOX5AP (0.44) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL2192769 0.81 ALDH1A1 (0.40) LMNAMAPTSMN1; SMN2CYP3A4CYP1A2
SCHEMBL931224 0.79 MAPT (0.51) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL3452134 0.79 MRGPRX4 (0.36) RAB9ALMNAMAPTL3MBTL1HPGD
SCHEMBL3452375 0.78 SMN1; SMN2 (0.40) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL18539809 0.76 RAB9A (0.54) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL20772141 0.75 ALDH1A1 (0.54) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2
SCHEMBL13673420 0.73 RAB9A (0.68) RAB9ALMNAMAPTSMN1; SMN2KMT2A
SCHEMBL2193582 0.73 RAB9A (0.39) RAB9ALMNAMAPTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858819-B2 Tris(formylphenyl) and novel polynuclear phenol derived therefrom HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-12-28 US disclosed
US-7858819-B2 Tris(formylphenyl) and novel polynuclear phenol derived therefrom HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-12-28 US disclosed
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-22 US disclosed
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM AS3MT, RRM2, SHROOM3 RAB9A 3688/4885LMNA 4332/4885MAPT 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.